Preclinical development

被引：0
|
作者：
不详
机构：
来源：
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 2002年
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：15 / 19
页数：5
相关论文
共 50 条
  • [21] PHARMACOTHERAPY OF COCAINE ABUSE - PRECLINICAL DEVELOPMENT
    WITKIN, JM
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1994, 18 (01): : 121 - 142
  • [22] Preclinical development and characterization of MYC inhibitors
    Jacob, Nicholas
    Miranda, Pedro
    Navarro, Pedro Serrano
    Hart, Jonathan
    Vogt, Peter
    Janda, Kim
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [23] Corallopyronin A: antimicrobial discovery to preclinical development
    Krome, Anna K.
    Becker, Tim
    Kehraus, Stefan
    Schiefer, Andrea
    Gutschow, Michael
    Chaverra-Munoz, Lillibeth
    Huttel, Stephan
    Jansen, Rolf
    Stadler, Marc
    Ehrens, Alexandra
    Pogorevc, Domen
    Muller, Rolf
    Hubner, Marc P.
    Hesterkamp, Thomas
    Pfarr, Kenneth
    Hoerauf, Achim
    Wagner, Karl G.
    Konig, Gabriele M.
    NATURAL PRODUCT REPORTS, 2022, 39 (09) : 1705 - 1720
  • [24] Modelling in preclinical and clinical drug development
    Balant, LP
    Gex-Fabry, M
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 15 - 29
  • [25] Preclinical development of lung targeted antimicrobials
    Mullen, PM
    Lollo, C
    Stevens, A
    Roben, P
    CRITICAL CARE MEDICINE, 2002, 30 (12) : A110 - A110
  • [26] Molecular pathology in the preclinical development of biopharmaceuticals
    Gillett, NA
    Chan, CM
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 48 - 52
  • [27] Roneparstat: Development, Preclinical and Clinical Studies
    Noseda, Alessandro
    Barbieri, Paola
    HEPARANASE: FROM BASIC RESEARCH TO CLINICAL APPLICATIONS, 2020, 1221 : 523 - 538
  • [28] Preclinical and clinical development of neoantigen vaccines
    Li, L.
    Goedegebuure, S. P.
    Gillanders, W. E.
    ANNALS OF ONCOLOGY, 2017, 28 : 11 - 17
  • [29] Flow cytometry in the preclinical development of biopharmaceuticals
    Gossett, KA
    Narayanan, PK
    Williams, DM
    Gore, ER
    Herzyk, DJ
    Hart, TK
    Sellers, TS
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 32 - 37
  • [30] Tyrosine kinase inhibitors in preclinical development
    Levitt, ML
    Koty, PP
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) : 213 - 226
12345